Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Penn Therapeutics, CRS

Philadelphia, Pennsylvania, United StatesNot linked to an institution yet

0running trials
5closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

No running trial is registered here.

Researchers

No researcher is linked here yet.

Closed trials

Terminated
A Study to Evaluate the Anti-inflammatory Effects of Letermovir (Prevymis) in Adults With Human Immunodeficiency Virus (HIV)-1 and Asymptomatic Cytomegalovirus (CMV) Who Are on Suppressive Antiretroviral Therapy, Plus Its Effect on Chronic Inflammation, HIV Persistence and Other Clinical Outcomes.
NCT04840199· Phase 2· Source
Completed
Trial to Evaluate the Safety and Immunogenicity of a Modified Vaccinia Ankara (MVA)-Based Anti-Cytomegalovirus (CMV) Vaccine (Triplex®)
NCT05099965· Phase 2· Source
Completed
B-Enhancement of HBV Vaccination in Persons Living With HIV (BEe-HIVe): Evaluation of HEPLISAV-B
NCT04193189· Phase 3· Source
Completed
Long-Acting Cabotegravir Plus VRC-HIVMAB075-00-AB (VRC07-523LS) for Viral Suppression in Adults Living With HIV-1
NCT03739996· Phase 2· Source
Completed
The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE
NCT03635788· Phase 3· Source

Site data: ClinicalTrials.govUpdated 3 Nov 2026

Report an error

Under construction, not live – Penn Therapeutics, CRS: trial site – Frontlight Research